Knightsbridge Asset Management, LLC Embecta Corp. Transaction History

Knightsbridge Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $193,200 - $285,549	-12,880 Reduced 8.16%	144,882 $2.18 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $3.47 Million - $4.93 Million	-160,480 Reduced 50.43%	157,762 $3.41 Million
Q1 2023 May 12, 2023	SELL	$23.07 - $32.77 $286,898 - $407,527	-12,436 Reduced 3.76%	318,242 $8.95 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $25,896 - $36,331	1,024 Added 0.31%	330,678 $8.36 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $11,280 - $15,707	-470 Reduced 0.14%	329,654 $9.49 Million
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $8.18 Million - $11 Million	330,124 New	330,124 $8.36 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Knightsbridge Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knightsbridge Asset Management, LLC with notifications on news.